Dan Lyons is a seasoned executive with SpringWorks Therapeutics (a Healthcare company of Merck KGaA) with over two decades of experience in pharma, driving innovation and growth. Currently serves as Senior Vice President, Head of International as well as well as Head of Global Market Access for Rare Tumor conditions. His career spans leadership roles at Sanofi, Eli Lilly, and other companies, where he had various commercial leadership roles, Rare Disease, Transplant & Oncology.